Therapeutic Potential of Coagonists of Glucagon and GLP-1

E-ISSN： 1875-6182|12|2|126-133

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.12, Iss.2, 2015-01, pp. : 126-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

By Holst J.J.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 6, 1999-08 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite

Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1: A Critical Review

By Baggio L.L. Drucker D.J.

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists

Current Diabetes Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 266-275

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon Like Peptide-1 (GLP-1) Dynamics Following Bariatric Surgery: A Signpost to a New Frontier

Current Diabetes Reviews, Vol. 9, Iss. 2, 2013-03 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome

Current Vascular Pharmacology, Vol. 15, Iss. 3, 2017-04 ,pp. : 218-229

Bentham Science Publishers

Access to resources Recommend Favorite